Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease - Related Studies

Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease

This study has been completed.

Study NCT00471393. Last updated on May 7, 2007. Information provided by University of Alberta, Graduate Orthodontic Program

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Joint Diseases
		Osteoarthritis

2	More general conditions related to this trial
		Arthritis
		Musculoskeletal Diseases
		Rheumatic Diseases

3	Interventions listed in this trial
		45.5% DMSO (topical placebo)

4	Additional drug interventions recognized in this trial
		Diclofenac

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		University of Alberta, Graduate Orthodontic Program
		University of Alberta